Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients

European Heart Journal

Volumn 30, Issue 16, 2009, Pages 2054-2061

  Koos, Ralf ^a   Brandenburg, Vincent ^a   Mahnken, Andreas Horst ^a   Mühlenbruch, Georg ^a   Stanzel, Sven ^a   Günther, Rolf W ^a   Floege, Jürgen ^a   Jahnen Dechent, Willy ^a   Kelm, Malte ^a   Kühl, Harald Peter ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Aortic valve stenosis; Calcification; Multi slice CT

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; FETUIN A; INSULIN; NICOTINE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE DISEASE; AORTA VALVE STENOSIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CALCIFICATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; UNIVARIATE ANALYSIS; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; AORTIC VALVE; BLOOD PROTEINS; CALCINOSIS; CORONARY ANGIOGRAPHY; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 68949097676     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp158     Document Type: Article

References (36)

1. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.
2. Moe SM, Reslerova M, Ketteler M, ÒNeill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005;67: 2295-2304.
3. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.
4. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW. Netherlands kooperative study on the adequacy of dialysis (NECOSAD). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007;72:202-207.
5. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease (abstract). Nephrol Dial Transplant 2004;19(Suppl. 5):V59-V66.
6. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW. Alpha2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277: 19991-19997.
7. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008;86:379-389.
8. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005;16:2920-2930.
9. Binkert C, Demetriou M, Sukhu B, Szweras M, Tenenbaum HC, Dennis JW. Regulation of osteogenesis by fetuin. J Biol Chem 1999;274:28514- 28520.
10. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem 1996;271: 12755-12761.
11. Mohler ER III, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999;8:254-260.
12. Jian B, Narula N, Li QY, Mohler ER III, Levy RJ. Progression of aortic valve stenosis: TGF-beta-1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003;75:457-465.
13. Westenfeld R, Schäfer C, Smeets R, Brandenburg V, Floege J, Ketteler M, Jahnen-Dechent W. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 2007;22:1537-1546.
14. Wang AYM, Woo J, Lam WKC, Wang M, Chang HSI, Gao P, Lui SF, Li KTP, Sanderson JE. Associations of serum fetuin-A with malnutrition, inflammation atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-1685.
15. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630-634.
16. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease. Data from the Heart and Soul study. Circulation 2007;115:2533-2539.
17. Kaden JJ, Reinöhl JO, Blesch B, Brueckmann M, Haghi D, Borggrefe M, Schmitz F, Klomfass S, Pillich M, Ortlepp JR. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int J Mol Med 2007;20:193-197.
18. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147.
19. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease. Pathogenesis, disease progression and treatment strategies. Circulation 2005;111:3316-3326.
20. Mahnken AH, Wildberger JE, Sinha AM, Flohr T, Truong HT, Krombach GA, Gunther RW. Variation of the coronary calcium score depending on image reconstruction interval and scoring algorithm. Invest Radiol 2002;37:496-502.
21. Agatston AS, Janowitz WR, Hildner J, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
22. Koos R, Mahnken AH, Sinha AM, Wildberger JE, Hoffmann R, Kuehl HP. Aortic valve calcification as a marker for aortic stenosis severity: assessment on 16-MDCT. Am J Roentgenol 2004;183:1813-1818.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
24. Grootendorst DC, de Jager DJ, Brandenburg VM, Boeschoten EW, Krediet RT, Dekker FW, The NECOSAD Study group. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 2007;22:3277-3284.
25. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, Sande FM, Gladziwa K, Reusma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM. Study on the relationship of serum-fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006;21:1293-1299.
26. Morghan-Hughes GJ, Owens PE, Roobottom CA, Marshall AJ. Three dimensional volume quantification of aortic valve calcification using multislice computed tomography. Heart 2003;89:1191-1194.
27. Budoff MJ, Katz R, Wong ND, Nasir K, Mao SS, Takasu J, Kronmal R, Detrano RC, Shavelle DM, Blumenthal RS, ÒBrien KD, Carr JJ. Effect of scanner type on the reproducibility of extracoronary measures of calcification: the multi-ethnic study of atherosclerosis. Acad Radiol 2007;14:1043- 1049.
28. Messika-Zeitoun D, Aubry MC, Detaint D, Bielak LF, Peyser PA, Sheedy PF, Turner ST, Breen JF, Scott C, Tajik AJ, Enriques-Sarano M. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004;110:356-362.
29. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schremper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-617.
30. Feuchtner GM, Müller S, Grander W, Alber HF, Bartel T, Friedrich GJ, Reinthaler M, Pachinger O, zur Nedden D, Dichtl W. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. J Heart Valve Dis 2006; 15:494-498.
31. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson J. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-1936.
32. Westenfeld R, Schäfer C, Krüger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W. Fetuin-A protects against atherosclerotic calcifications in mice with renal failure. J Am Soc Nephrol 2009; in press.
33. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimburger O, Holmes C, Schalling M, Nordfors L. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.
34. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif 2005;23: 64-71.
35. Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, Otto CM, Griffin BP. Clinical factors, but not C-reactive protein, predict progression of calcific aortic valve disease the cardiovascular health study. J Am Coll Cardiol 2007;50: 1992-1998.
36. Caglar K, Yilmaz MI, Saglam M, Cahir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases serum fetuin-A concentrations and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol 2008;3:61-68.